Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and third
leading cause of cancer-related mortality worldwide. While surgical resection and …

Abstract Treatment of hepatocellular carcinoma (HCC) depends on the stage of disease. In
the Western Hemisphere, the Barcelona Clinic Liver Cancer classification (BCLC) is the …

Transcatheter arterial chemoembolization (TACE) is widely used for the treatment of
advanced hepatocellular carcinoma (HCC). However, the long-term hypoxic …

Background Drug‐eluting beads bronchial arterial chemoembolization (DEB‐BACE) can
embolize the tumor‐feeding artery and also be loaded with antitumor drugs, which can be …

Globally, primary liver cancer is the third leading cause of cancer-related deaths, with
approximately 830 000 deaths worldwide in 2020, accounting for 8.3% of total deaths from …

Simple Summary Liver metastases of colorectal cancer have an enormous clinical impact
and prevalence. As colorectal cancer is one of the most common cancers, such patients are …

The safety and efficacy of drug-eluting beads transarterial chemoembolization (DEB-TACE)
for unresectable renal cell carcinoma (RCC) still unknown. We aimed to assess the …

Objective To compare the efficacy and safety of TACE combined with Donafenib and
Toripalimab versus TACE combined with Sorafenib in the treatment of unresectable …

Simple Summary Primary liver cancer is the third most common cause of cancer-related
deaths worldwide. Risk factors for primary liver cancer include chronic viral hepatitis B and C …

Chitosan is a natural polysaccharide that is considered to be biocompatible, biodegradable
and non-toxic. The polymer has been used in drug delivery applications for its positive …